Furthermore, Proguanil, an anti-malaria drug that targets DHFR, has been suggested to play a role in preventing some cancers by enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy 52,53. The gene discussed is DHFR; the disease is malaria.